{
    "root": "385b0750-5e02-416e-b01d-2e26e67da2bd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Divalproex Sodium",
    "value": "20250310",
    "ingredients": [
        {
            "name": "DIVALPROEX SODIUM",
            "code": "644VL95AO6"
        },
        {
            "name": "D&C RED NO. 30",
            "code": "2S42T2808B"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST)",
            "code": "87Y6436BKR"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED",
            "code": "2165RE0K14"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        }
    ],
    "indications": "Divalproex sodium delayed-release tablet is an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar      disorder ( 1.1 ) Monotherapy and adjunctive therapy of complex partial      seizures and simple and complex absence seizures; adjunctive therapy in      patients with multiple seizure types that include absence seizures      ( 1.2 ) Prophylaxis of migraine headaches      ( 1.3 )",
    "contraindications": "Divalproex sodium delayed-release tablets are administered      orally in divided doses. Divalproex sodium delayed-release tablets should      be swallowed whole and should not be crushed or chewed ( 2.1 , 2.2 ). Mania: Initial dose is 750 mg daily, increasing as rapidly      as possible to achieve therapeutic response or desired plasma level ( 2.1 ).      The maximum recommended dosage is 60 mg/kg/day ( 2.1 , 2.2 ). Complex Partial Seizures: Start at 10 to 15 mg/kg/day,      increasing at 1 week intervals by 5 to 10 mg/kg/day to achieve optimal      clinical response; if response is not satisfactory, check valproate plasma      level; see full prescribing information for conversion to monotherapy ( 2.2 ).      The maximum recommended dosage is 60 mg/kg/day ( 2.1 , 2.2 ). Absence Seizures: Start at 15 mg/kg/day, increasing at 1      week intervals by 5 to 10 mg/kg/day until seizure control or limiting side      effects ( 2.2 ). The maximum recommended dosage      is 60 mg/kg/day ( 2.1 , 2.2 ). Migraine: The recommended starting dose is 250 mg twice      daily, thereafter increasing to a maximum of 1,000 mg/day as needed ( 2.3 ).",
    "warningsAndPrecautions": null,
    "adverseReactions": "Hepatic      disease or significant hepatic dysfunction ( 4 , 5.1 ) Known      mitochondrial disorders caused by mutations in mitochondrial DNA      polymerase Î³ (POLG) ( 4 , 5.1 ) Suspected      POLG-related disorder in children under two years of age ( 4 , 5.1 ) Known      hypersensitivity to the drug ( 4 , 5.12 ) Urea cycle      disorders ( 4 , 5.6 ) Prophylaxis      of migraine headaches: Pregnant women, women of childbearing potential not      using effective contraception ( 4 , 8.1 )"
}